<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01092481</url>
  </required_header>
  <id_info>
    <org_study_id>2009-11-008</org_study_id>
    <secondary_id>2009-11-008</secondary_id>
    <nct_id>NCT01092481</nct_id>
  </id_info>
  <brief_title>Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy</brief_title>
  <official_title>A Randomized Phase III Study Investigating the Role of Oxaliplatin Duration (3 Months Versus 6 Months) in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Therapy for Patients With Stage II/III Colon Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to confirm that first 3 months of oxaliplatin in 6 months of modified
      FOLFOX-6 or CAPOX treatment is not inferior to 6 months of oxaliplatin in modified FOLFOX-6
      or CAPOX treatment in terms of disease free survival in patients with stage II/III colon
      cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is designed to confirm that first 3 months of oxaliplatin in 6 months of modified
      FOLFOX-6 or CAPOX treatment is not inferior to 6 months of oxaliplatin in modified FOLFOX-6
      or CAPOX treatment in terms of disease free survival in patients with stage II/III colon
      cancer. In addition, we would like to characterize pharmacogenomic profile associated with
      toxicities and gene expression profiling to predict the recurrence of colon cancer as
      parallel study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 26, 2010</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>disease-free survival</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>overall survival</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>safety profiles</measure>
    <time_frame>3 years</time_frame>
    <description>Safety will be assessed on the basis of an analysis of adverse events, standard clinical chemistry and hematology findings. Clinical and laboratory toxicities/symptoms will be graded according to the CTCAE 3.0. Adverse events which are not reported in CTCAE 3.0 will be graded as mild, moderate, severe or life threatening.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2660</enrollment>
  <condition>Colon Cancer</condition>
  <arm_group>
    <arm_group_label>FOLFOX_12 or CAPOX_8</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>6 months of oxaliplatin in 12 cycles of modified FOLFOX-6 or 8 cycles of CAPOX</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FOLFOX_6 or CAPOX_4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 months of oxaliplatin in 12 cycles of modified FOLFOX-6 or 8 cycles of CAPOX</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oxaliplatin</intervention_name>
    <description>to confirm that first 3 months of oxaliplatin in 12 cycles of modified FOLFOX-6 or 8 cycles of CAPOX treatment is not inferior to 6 months of oxaliplatin in modified FOLFOX-6 or CAPOX treatment in terms of disease free survival in patients with stage II/III colon cancer.</description>
    <arm_group_label>FOLFOX_12 or CAPOX_8</arm_group_label>
    <arm_group_label>FOLFOX_6 or CAPOX_4</arm_group_label>
    <other_name>oxaliplatin (modified FOLFOX-6 OR CAPOX)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Curatively resected, histologically confirmed colon adenocarcinoma

          -  AJCC/UICC high-risk stage II, stage III colon cancer

          -  Age over 18 years old

          -  Performance status (ECOG scale): 0-1

          -  Adequate major organ functions

          -  Patients should sign a written informed consent before study entry

        Exclusion Criteria:

          -  Colon cancer other than adenocarcinoma

          -  Rectal cancer

          -  R1 or R2 resections

          -  Other malignancies within the last 5 years

          -  Symptomatic peripheral sensory neuropathy

          -  Presence of other serious disease

          -  Lactating or pregnant women

          -  Fertile women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Young Suk Park, M.D.,Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center, Seoul, Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Young Suk Park, M.D.,Ph.D.</last_name>
    <phone>82-2-3410-3459</phone>
    <email>pys27hmo@skku.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hallym University Medical Center</name>
      <address>
        <city>Anyang</city>
        <state>Gyeonggi</state>
        <zip>431-070</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dae Young Zang, M.D., Ph.D</last_name>
      <phone>82-31-380-3871</phone>
      <email>fhdzang@hallym.or.kr</email>
    </contact>
    <investigator>
      <last_name>Dae Young Zang, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soon Chun Hyang University Hospital Bucheon</name>
      <address>
        <city>Bucheon</city>
        <state>Gyeonggi</state>
        <zip>420-767</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dae Sik Hong, M.D., Ph.D</last_name>
      <phone>82-32-621-5104</phone>
      <email>dshong@schbc.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Dae Sik Hong, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Cancer Center</name>
      <address>
        <city>Goyang</city>
        <state>Gyeonggi</state>
        <zip>410-768</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sun Young Kim, M.D., Ph.D</last_name>
      <phone>82-31-920-1661</phone>
      <email>cathykimmd@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Sun Young Kim, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>School of Medicine, CHA University</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi</state>
        <zip>463-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doyeun Oh, M.D., Ph.D</last_name>
      <phone>82-31-780-5217</phone>
      <email>doh@cha.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Doyeun Oh, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sungkyunkwan University Masan Samsung Hospital</name>
      <address>
        <city>Masan</city>
        <state>Gyeongsangnam</state>
        <zip>630-522</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyung Tae Park, M.D., Ph.D</last_name>
      <phone>82-55-290-6007</phone>
      <email>pkt@unitel.co.kr</email>
    </contact>
    <investigator>
      <last_name>Kyung Tae Park, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pusan National University Yangsan Hospital</name>
      <address>
        <city>Yangsan</city>
        <state>Gyeongsangnam</state>
        <zip>626-770</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seong - Geun Kim, M.D., Ph.D</last_name>
      <phone>82-55-360-1424</phone>
      <email>patheny@nate.com</email>
    </contact>
    <investigator>
      <last_name>Seong - Geun Kim, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chonnam National University Hwasun Hospital</name>
      <address>
        <city>Hwasun</city>
        <state>Jeollanam</state>
        <zip>519-809</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ik Joo Chung, M.D., Ph.D</last_name>
      <phone>82-61-379-7632</phone>
      <email>ijchung@jnu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Ik Joo Chung, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kosin Medical Center</name>
      <address>
        <city>Busan</city>
        <zip>602-702</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seong-Hoon Shin, M.D., Ph.D</last_name>
      <phone>82-51-990-6107</phone>
      <email>ssh1533@hanmail.net</email>
    </contact>
    <investigator>
      <last_name>Seong-Hoon Shin, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dong-A University Medical Center</name>
      <address>
        <city>Busan</city>
        <zip>602-715</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyuk-Chan Kwon, M.D., Ph.D</last_name>
      <phone>82-51-240-2887</phone>
      <email>hckwon@dau.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Hyuk-Chan Kwon, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gachon University Gil Hospital</name>
      <address>
        <city>Incheon</city>
        <zip>405-760</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong Bok Shin, M.D., Ph.D</last_name>
      <phone>82-32-460-2187</phone>
      <email>dbs@ghil.com</email>
    </contact>
    <investigator>
      <last_name>Dong Bok Shin, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joong Bae Ahn, M.D., Ph.D</last_name>
      <phone>82-2-2228-8134</phone>
      <email>vvswm513@yuhs.ac</email>
    </contact>
    <investigator>
      <last_name>Joong Bae Ahn, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Suk Park, M.D.,Ph.D.</last_name>
      <phone>82-2-3410-3459</phone>
      <email>pys27hmo@skku.edu</email>
    </contact>
    <investigator>
      <last_name>Ho-Kyung Chun, M.D., Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Woo Yong Lee, M.D., Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Seong Hyeon Yun, M.D., Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hee Cheol Kim, M.D., Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yong Beom Cho, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Haeran Yun, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Won Ki Kang, M.D., Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ho Yeong Lim, M.D., Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joon Oh Park, M.D., Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Se Hoon Park, M.D., Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeeyun Lee, M.D., Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul St. Mary's hospital, Catholic Univerisity</name>
      <address>
        <city>Seoul</city>
        <zip>137-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Myung Ah Lee, M.D., Ph.D</last_name>
      <phone>82-2-2258-6044</phone>
      <email>angelamd@catholic.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Myung Ah Lee, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tae Won Kim, M.D., Ph.D</last_name>
      <phone>82-2-3010-3210</phone>
      <email>twkimmd@amc.seoul.kr</email>
    </contact>
    <investigator>
      <last_name>Tae Won Kim, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soonchunhyang University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>140-210</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nam Su Lee, M.D., Ph.D</last_name>
      <phone>82-2-709-9287</phone>
      <email>mdnslee@hosp.sch.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Nam Su Lee, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SMG-SNU Boramae Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>156-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>In Sil Choi, M.D., Ph.D</last_name>
      <phone>82-2-870-2231</phone>
      <email>hmoischoi@hanmail.net</email>
    </contact>
    <investigator>
      <last_name>In Sil In Sil, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chung-Ang University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>156-755</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joung Soon Jang, M.D., Ph.D</last_name>
      <phone>82-2-6299-1427</phone>
      <email>alsaba@hanmail.net</email>
    </contact>
    <investigator>
      <last_name>Joung Soon Jang, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2009</study_first_submitted>
  <study_first_submitted_qc>March 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2010</study_first_posted>
  <last_update_submitted>January 15, 2018</last_update_submitted>
  <last_update_submitted_qc>January 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Young Suk Park</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Adjuvant FOLFOX or CAPOX Therapy</keyword>
  <keyword>Stage II/III Colon Cancer</keyword>
  <keyword>Adjuvant Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxaliplatin</mesh_term>
    <mesh_term>Fluorouracil</mesh_term>
    <mesh_term>Leucovorin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

